JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 15, 2005; DOI: 10.1124/jpet.104.081521


0022-3565/05/3141-139-147$20.00
JPET 314:139-147, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.081521v1
314/1/139    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Melendez, R. I.
Right arrow Articles by Kalivas, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melendez, R. I.
Right arrow Articles by Kalivas, P. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ASPARTIC ACID
*GLUTAMIC ACID HYDROCHLORIDE

NEUROPHARMACOLOGY

Regulation of Extracellular Glutamate in the Prefrontal Cortex: Focus on the Cystine Glutamate Exchanger and Group I Metabotropic Glutamate Receptors

Roberto I. Melendez, Jompobe Vuthiganon, and Peter W. Kalivas

Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina

Microdialysis was used to determine the in vivo processes contributing to extracellular glutamate levels in the prefrontal cortex of rats. Reverse dialysis of a variety of compounds proved unable to decrease basal levels of extracellular glutamate, including Na+ and Ca2+ channel blockers, cystine/glutamate exchange () antagonists, and group I (mGluR1/5) and group II (mGluR2/3) metabotropic glutamate receptor (mGluR) agonists or antagonists. In contrast, extracellular glutamate was elevated by blocking Na+-dependent glutamate uptake () with DL-threo-{beta}-benzyloxyaspartate (TBOA) and stimulating group I mGluRs with (R,S)-3,5-dihydroxy-phenylglycine (DHPG). The accumulation of extracellular glutamate produced by blocking was completely reversed by inhibiting system with 4-carboxyphenylglycine (CPG), but not by Na+ and Ca2+ channel blockers. Because CPG also inhibits group I mGluRs, two additional group I antagonists were examined, LY367385 [(+)-2-methyl-4-carboxyphenylglycine] and (R,S)-1-aminoindan-1,5-dicarboxylic acid (AIDA). Whereas LY367385 also reduced TBOA-induced increases in extracellular glutamate, AIDA did not. In contrast, all three group I antagonists reversed the increase in extracellular glutamate elicited by stimulating mGluR1/5. In vitro evaluation revealed that similar to CPG, LY367385 inhibited and that stimulating or inhibiting mGluR1/5 did not directly affect [3H]glutamate uptake via or . These experiments reveal that although inhibiting cannot reduce basal extracellular glutamate in the prefrontal cortex, the accumulation of extracellular glutamate after blockade of arises predominately from . The accumulation of glutamate elicited by mGluR1/5 stimulation does not seem to result from modulating , or synaptic glutamate release.


Received December 1, 2004; accepted March 1, 2005.

Address correspondence to: Dr. Roberto I. Melendez, Department of Neurosciences, Medical University of South Carolina 173 Ashley Ave., Suite 403 BSB, Charleston, SC 29425. E-mail: melendez{at}musc.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. N. Hascup, E. R. Hascup, F. Pomerleau, P. Huettl, and G. A. Gerhardt
Second-by-Second Measures of L-Glutamate in the Prefrontal Cortex and Striatum of Freely Moving Mice
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 725 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Madayag, D. Lobner, K. S. Kau, J. R. Mantsch, O. Abdulhameed, M. Hearing, M. D. Grier, and D. A. Baker
Repeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine
J. Neurosci., December 19, 2007; 27(51): 13968 - 13976.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
D. Durstewitz and T. Gabriel
Dynamical Basis of Irregular Spiking in NMDA-Driven Prefrontal Cortex Neurons
Cereb Cortex, April 1, 2007; 17(4): 894 - 908.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Namkoong, S.-S. Shin, H. J. Lee, Y. E. Marin, B. A. Wall, J. S. Goydos, and S. Chen
Metabotropic Glutamate Receptor 1 and Glutamate Signaling in Human Melanoma
Cancer Res., March 1, 2007; 67(5): 2298 - 2305.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Y. Shih, H. Erb, X. Sun, S. Toda, P. W. Kalivas, and T. H. Murphy
Cystine/Glutamate Exchange Modulates Glutathione Supply for Neuroprotection from Oxidative Stress and Cell Proliferation
J. Neurosci., October 11, 2006; 26(41): 10514 - 10523.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.